Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis
Journal of Clinical Medicine · 23.02.2025 · 14 (5) · 1491
DOI: 10.3390/jcm14051491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.02.2025. Verfasst von Akira Sakamaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Objective
Liver cirrhosis (LC) progression induces intestinal microbiota abnormalities, such as small intestinal bacterial overgrowth (SIBO), and these changes lead to the inflow of gut pathogens and their degradation products into the vessels, causing cirrhotic complications such as hepatic encephalopathy (HE).
Methods
To clarify the relationship between the development of overt HE and SIBO, we conducted a three-year observation after assessment of SIBO in patients with LC.
Results
In the analysis of 107 patients, with a mean follow-up duration of 29.4 months, 31 were diagnosed with SIBO and 30 with covert HE. In the Cox multivariate regression analysis for prognosis, the Child–Pugh score, blood urea nitrogen level, and the Union for International Cancer Control (UICC) stage of hepatocellular carcinoma were derived using the following five factors: white blood cell count, blood urea nitrogen level, Child–Pugh score, UICC stage, and serum aspartate aminotransferase and alkaline phosphatase levels (p = 0.002, hazard ratio [HR] 3.733, 95% confidence interval [CI] 1.592–8.754, p = 0.001, HR 1.076, 95% CI 1.030–1.123, and p < 0.001, HR 2.767, 95% CI 1.780–4.302, respectively). Furthermore, in the Cox multivariate regression analysis for overt HE development, covert HE and methane-producing SIBO were derived using the following four factors: methane-producing SIBO, UICC stage, covert HE, and serum ammonia levels (p = 0.038, HR 5.008, 95% CI 1.096–22.892 and p = 0.006, HR 8.597, 95% CI 1.881–39.291, respectively).
Conclusions
M-SIBO positivity was a significant predictor of overt HE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
- Division of Gastroenterology and Hepatology, Niigata Prefectural Hospital, Niigata 943-0192, Japan.
- Department of General Medicine, Niigata University School of Medicine, Niigata 951-8510, Japan.
- Division of Gastroenterology and Hepatology, Saiseikai Niigata Hospital, Niigata 950-1104, Japan.
ORCID-Profile: Yuichi Kojima, Atsunori Tsuchiya, Kenya Kamimura
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Sakamaki, A., Yokoyama, K., Yamazaki, H., Wakabayashi, T., Kojima, Y., Tominaga, K., Tsuchiya, A., Kamimura, K., Yokoyama, J., & Terai, S. (2025). Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis. Journal of Clinical Medicine, 14(5), 1491. https://doi.org/10.3390/jcm14051491
Vancouver
Sakamaki A, Yokoyama K, Yamazaki H, Wakabayashi T, Kojima Y, Tominaga K, et al. Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis. Journal of Clinical Medicine. 2025;14(5):1491. doi:10.3390/jcm14051491
BibTeX
@article{Sakamaki2025,
author = {Sakamaki, Akira and Yokoyama, Kunihiko and Yamazaki, Hanako and Wakabayashi, Takuya and Kojima, Yuichi and Tominaga, Kentaro and Tsuchiya, Atsunori and Kamimura, Kenya and Yokoyama, Junji and Terai, Shuji},
title = {Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {5},
pages = {1491},
doi = {10.3390/jcm14051491}
}
EUVIMED